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Individuals with chronic obstructive pulmonary disease (COPD) are often limited in their
ability to perform exercise due to a heightened sense of dyspnea and/or the occurrence
of leg fatigue associated with a reduced ventilatory capacity and peripheral skeletal
muscle dysfunction, respectively. Pulmonary rehabilitation programs have been shown
to improve exercise tolerance and health related quality of life. Additional therapeutic
approaches such as non-invasive ventilatory support (NIVS), heliox (HeeO2) and supple-
mental oxygen have been used as non-pharmacologic adjuncts to exercise to enhance
the ability of patients with COPD to exercise at a higher exercise-intensity and thus
improve the physiological benefits of exercise. The purpose of the current review is to
examine the pathophysiology of exercise limitation in COPD and to explore the physiolog-
ical mechanisms underlying the effect of the adjunct therapies on exercise in patients
with COPD. This review indicates that strategies that aim to unload the respiratory
muscles and enhance oxygen saturation during exercise alleviate exercise limiting factors
and improve exercise performance in patients with COPD. However, available data showsacre´-Cœur de Montre´al, Axe de recherche en sante´ respiratoire, 5400 boul. Gouin Ouest, Montre´al,
43382222x3654; fax: þ1 5147397357.
mcgill.ca (J. Spahija).
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Mechanisms of adjunct therapies in COPD 615significant variability in the effectiveness across patients. Further research is needed to
identify the most appropriate candidates for these forms of therapies.
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Chronic obstructive pulmonary disease (COPD) is a pulmo-
nary disorder that is characterized by progressive irre-
versible airflow limitation resulting from alveolar wall
destruction, bronchiolar narrowing1 and airway inflamma-
tion that occurs in response to inhalation of noxious parti-
cles or gases.2 Although numerous genetic, occupational,
and environmental factors have been associated with
COPD,3e5 cigarette smoking remains the primary cause of
the disease.6 COPD is a major cause of morbidity and
mortality and poses a substantial economic and social
burden worldwide.1,2
Individuals with COPD commonly exhibit a limited ability
to perform exercise.2,7,8 Compared to healthy individuals,
patients with COPD demonstrate lower maximum exercise
capacities and lower levels of peak oxygen consumption
(VO2peak),
9e11 with the lowest levels observed in patients
with more severe COPD.10e12 Although moderate correla-
tions between VO2peak and the force expiratory volume in
the first second (FEV1) have been reported in patients with
mild (rZ 0.69), moderate (rZ 0.65), and severe (rZ 0.87)
COPD, others have found FEV1 to be a poor predictor of
exercise capacity.13e15 Patients with COPD typically expe-
rience dyspnea during exercise; however, the locus of
symptom limitation (i.e., the reason for stopping exercise)
is not uniform across patients.16 Whereas the majority
patients with COPD stop exercise because of dyspnea,
others are limited by leg fatigue or a combination of
dyspnea and leg fatigue. Compared to individuals with mild
COPD, those with moderate-to-severe disease tend to
perceive dyspnea more intensely than leg fatigue.17
However, patients with COPD also exhibit skeletal muscleabnormalities, which can contribute to exercise intoler-
ance.18 Although the exact proportion varies among
studies, leg fatigue has been reported as the primary
symptom limiting exercise during cycling in approximately
one third of the patients with COPD.17,19 Some studies have
also reported a moderate correlation between leg discom-
fort during exercise and the magnitude of contractile
muscle fatigue in patients with COPD.19,20
In an effort to help reduce dyspnea and improve exer-
cise capacity, individuals with COPD are often referred to
pulmonary rehabilitation programs.21e24 Such programs
typically use a multidisciplinary approach, combining
education and exercise to optimize physical and social
performance and autonomy. However, exercise training
has been shown to be the essential component for
improving exercise capacity and health related quality of
life (HRQoL).21e23,25e28 The physiological benefits associ-
ated with high intensity exercise training include a reduc-
tion of exercise lactic acidosis and heart rate for a given
work rate,29 which in turn leads to a lower ventilatory
demand and a more effective breathing pattern,30
enhanced activity of mitochondrial enzymes and capillary
density in the trained muscles,30,31 as well as enhanced
anabolic processes in the peripheral muscles.32 There is
also some evidence that whole body aerobic exercise
training may improve respiratory muscle function in
patients with COPD, as demonstrated by an increase in the
maximum inspiratory muscles pressure.33e35 While low
intensity exercise training has also been shown to be
effective in improving exercise tolerance with regard to
endurance for activities such as walking, it does not lead
to the same physiologic training effect that can result from
high intensity training.29 Although studies suggest that
616 A.M. Moga et al.most patients with COPD can benefit from pulmonary
rehabilitation,2,27,29,30,36,37 some individuals with severe
lung disease may be unable to obtain a true physi-
ological training effect because of their inability to exer-
cise at a high enough exercise-intensity (i.e., 80% of
maximum).2,29
Therapeutic approaches such as non-invasive ventilatory
support (NIVS),22,38,39 low-density gases (i.e. Heliox),40,41
and supplemental oxygen (O2)
42,43 have been used as non-
pharmacologic adjuncts to exercise training to enhance
the ability of patients with COPD to exercise at a higher
exercise-intensity and thus improve the physiological
benefits of exercise.
The current review examines the factors that
contribute to exercise limitation in COPD and the physi-
ological mechanisms via which non-pharmacologic adjunct
therapies may improve exercise tolerance. Understanding
how these adjunct therapies affect the factors contrib-
uting to exercise limitation is of paramount impo-
rtance for guiding identification of the most appropriate
forms of therapy for improving exercise in such
individuals.Figure 1 Ventilatory response to incremental exercise is shown
Changes in dyspnea intensity (upper left), operational lung volum
displacement ratio (lower right) are shown as ventilation increas
pattern is more rapid and shallow in COPD (solid circles) compar
constraints on tidal volume (VT) are evident in COPD because o
above by the total lung capacity (TLC). To increase ventilation,
a greater extent. Tidal inspiratory pressure swings expressed as a f
relative to the VT response expressed as a fraction of the predi
COPD.8 Reprinted with permission of the American Thoracic Soc
Journal of the American Thoracic Society.Exercise limitation in COPD
Ventilatory limitation and work of breathing
The changes that occur to the mechanical properties of the
lungs in COPD contribute to an increased work of
breathing44,45 and impaired gas exchange.2 Expiratory flow
limitation resulting from airway inflammation and loss of
lung elasticity46 leads to air trapping within the lungs which
increases the end-expiratory lung volume (i.e. static
pulmonary hyperinflation).47e49 During exercise, minute
ventilation (VE) is increased predominantly by an increased
respiratory rate (RR), whereas tidal volume (VT), which
approaches the limits of total lung capacity at end-
inspiration, increases marginally before reaching
a plateau (Fig. 1).50 The increased RR results in less time
available for exhalation, and leads to further increases in
end-expiratory lung volume (i.e. dynamic hyper-
inflation).49e52 Because the respiratory system is less
compliant at higher lung volumes, static and dynamic
hyperinflation contribute to an increase in the inspiratory
elastic work of breathing. This is further compounded by anin patients with COPD and in age-matched healthy individuals.
es (upper right), breathing pattern (lower left) and the effort-
es with exercise. Dyspnea intensity is greater and breathing
ed to healthy individuals (open circles). Greater mechanical
f increasing end-expiratory ling volumes and limitation from
individuals with COPD increase breathing frequency (F ) to
raction of their maximal force-generating capacity (Pes/PImax)
cted vital capacity (VC) show a significantly steeper slope in
iety. Copyright (ª) 2012 American Thoracic Society. Official
Mechanisms of adjunct therapies in COPD 617inspiratory threshold load whereby patients with COPD
must often generate an inspiratory threshold pressure
before airflow occurs, i.e. intrinsic positive end-expiratory
pressure (PEEPi).53
The development of hyperinflation additionally
decreases inspiratory muscle length, which reduces the
ability of such muscles to generate force.54 Dynamic
hyperinflation therefore contributes to neuromechanical
uncoupling whereby an increased inspiratory effort is
required to generate a given ventilatory output. Under
conditions of impaired lengthetension relationship54 and
reduced coupling, COPD patients need to increase central
respiratory drive and diaphragm activation55e57 in order to
maintain the same pressure generated across the dia-
phragm (i.e. transdiaphragmatic pressure)57 (Fig. 2). This
increased activation has been associated with greater
respiratory effort sensation,48,50,56 increased energy
demands,58,59 as well as enhanced inspiratory muscle
fatigability.57,58,60,61Peripheral muscle dysfunction
In addition to the clear evidence of dynamic hyperinflation
and altered pulmonary mechanics contributing to exercise
intolerance in COPD, peripheral muscle dysfunction also
appears to play an important role in limiting exercise in
such individuals.2,17,62
The skeletal muscle abnormalities that occur in COPD
result from both deconditioning63 secondary to decreased
activity levels,31 and from systemic inflammation.64,65
These abnormalities are characterized by a reduction inFigure 2 Campbell diagram showing the volume of lung or chest w
dynamic hyperinflation on inspiratory muscle work. FRC: functional
breath from FRC; arrows show direction. The dashed line shows t
pressure), and the dotted line shows the elastic characteristic of
inspiratory muscles (length of the horizontal arrow). PEEPi, intri
before inspiratory flow can begin (length of the horizontal arrow).
stippled area is work done against elastance of lung and chest wall
Illustrates the FRC is equal to Vrel, the relaxation volume of the resp
above relaxation volume in an individual with COPD. In COPD, the w
elastic characteristics of lung and chest wall are unchanged. Ref.the proportion of type I fatigue-resistant fibers,66,67
increased proportion of less efficient type II fibers,68,69
reduced cross-sectional area of type I fibers i.e. muscle
atrophy,66,68 and a reduced oxidative enzyme activity.70
Several studies have shown a relationship of such changes
with reduced peripheral muscle strength and endurance, as
well as an increased contractile fatigability.62,68,70,71
Contractile muscle fatigue has been defined as a revers-
ible reduction in the capacity of the skeletal muscle to
generate force in response to a given neural input.72,73
Evidence for the occurrence of quadriceps contractile
fatigue during exercise in patients with COPD comes from
several studies that have assessed quadriceps muscle
strength via magnetic stimulation.74e78 Studies have shown
quadriceps strength to be correlated with maximum exer-
cise capacity, independent of pulmonary function.71,77,79
Saey et al.77 demonstrated that even after an improve-
ment in FEV1 following bronchodilator medication, quadri-
ceps contractile fatigue was still evident following
endurance cycling in a subgroup of patients who previously
reported leg fatigue as being the primary factor limiting
maximum exercise. These findings suggest that the pres-
ence of leg fatigue modulates the exercise response to
bronchodilation.
Although muscle fatigue is a complex phenomenon,
changes in muscle energy metabolism may be involved.77
Several studies have found that compared with age-
matched healthy individuals, COPD patients have lower
lactate thresholds (i.e. VO2 at which blood lactic acid
begins to increase).63,80 The lower lactate thresholds lead
to an excessive accumulation of metabolic by-products
during exercise,29,81 which further impairs contractilityall (VL) plotted against pleural pressure (PPl) and the effects of
residual capacity. The continuous line (loop) traces a complete
he elastic characteristic of the lung (negative of elastic recoil
the relaxed chest wall. Pmus, pressure change generated by
nsic positive end-expiratory pressure that must be overcome
The diagonally hatched area is work done against resistance,
, and horizontally hatched area is work to overcome PEEPi. (A)
iratory system in a healthy individual, and (B) FRC is increased
ork done against inspiratory resistance is increased whereas the
53.
618 A.M. Moga et al.and increases the risk of fatigue in patients with COPD.18
The increased CO2 production also further increases the
ventilatory demand and induces ventilatory limitation at
lower than normal exercise workloads,82 thus causing early
exercise termination in such patients.2,7,17Cardiac function and blood distribution
Cardiac output (CO), which is the body’s energy supply and
the product of stroke volume and heart rate (HR) is regu-
lated principally by the demand for O2 by the cells of the
body.83 In general, the exercise-induced increase in VO2 is
achieved by an increased CO and an increased O2 extraction
at the level of the working respiratory and peripheral
skeletal muscles. During both sub-maximal and maximal
exercise in healthy individuals, CO increases nearly linearly
with VO2, suggesting that O2 consumption is linearly related
to the energy supply.84e86 Although COPD patients likewise
present an almost linear CO and VO2 relationship during
sub-maximal exercise,87e89 HR has been reported to be
higher than normal at any given VO2,
90 implying that stroke
volume (SV) is lower than normal.91 In the absence of
coexisting left-sided heart disease, evidence suggests that
the decreased SV occurs secondary to reduced right
ventricular ejection fraction at rest and which, on average,
fails to increase with exercise among patients with
COPD.92e94 As with CO, blood flow to the exercising
peripheral muscles at a given sub-maximal exercise work
rate is similar in patients with COPD and healthy individ-
uals.11,81 In contrast, individuals with COPD reach lower
peak exercise work rates and exhibit a reduced peak VO2
(30e50% lower) and peak CO (35e60% lower) with a normal
or reduced HR, as well as a lower peak leg blood flow
compared to healthy individuals.9e11,87e89,95e97
Dynamic hyperinflation appears to have a significant
impact on cardiovascular function during exercise in
patients with COPD.91 Vassaux et al.98 showed a strong
association (rZ 0.87) between inspiratory-to-total lung
capacity ratio (IC/TLC represents an index of hyperinfla-
tion) at rest and exercise and O2 pulse (i.e. VO2/HR,
a surrogate marker of cardiac function), demonstrating that
the most hyperinflated patients (i.e. IC/TLC 0.25%, an
indicator of severe static hyperinflation), had a lower peak
exercise O2 pulse at a similar work load than patients
having less hyperinflation (i.e., IC/TLC> 0.25%).98 In an
attempt to maintain the required ventilation during exer-
cise when the ability to increase O2 supply is limited,
individuals with severe hyperinflation are forced to
generate a larger intra-thoracic pressure.92,99 This in turn,
limits venous return, right and left ventricular (LV) blood
volumes, and consequently, cardiac output.92,100,101 In
addition, loss of pulmonary vascular capacity with emphy-
sema results in an increased pulmonary vascular resistance
which may ultimately impair LV filling. Barr et al.101 re-
ported that the severity of airflow obstruction (FEV1/FVC)
and the degree of emphysema on chest CT scans was
inversely correlated with reductions in LV end-diastolic
volume, stroke volume and CO. Although there was
a stronger association in more severe patients, hemody-
namic changes also occurred with mild emphysema and
airflow obstruction. Watz et al.102 reported that IC/TLC wasmore strongly correlated with cardiac chamber size than
measurements of airway obstruction or diffusion capacity,
and that COPD patients with IC/TLC 0.25% not only have
an impaired LV filling, but also a reduced functional
capacity as indicated by a lower 6-min walk distance.
Several studies have suggested10,103e105 that when the
energy demands of the respiratory muscles are increased,
such as during exercise, a competition for blood flow
develops between the respiratory and peripheral muscles,
which ultimately favors a redistribution of blood flow from
the locomotor to the respiratory muscles. Evidence for this
phenomenon, known as the “respiratory steal” or “blood
stealing effect”,103 comes from Simon et al.,106 who found
that about 45% of the patients with COPD participating in
their study demonstrated a leg blood flow plateau during
whole body incremental cycling exercise, despite
increasing exercise work load. They additionally found that
the patients who exhibited such a leg blood flow plateau
also revealed a greater work of breathing at sub-maximal
exercise, indicating a high O2 demand of the respiratory
muscles.106 In this context, it has been suggested that
reduction in blood flow to the working peripheral muscles
may induce leg fatigue, thereby limiting the duration and
the intensity of exercise in patients with COPD as demon-
strated by other studies.82,107
Non-pharmacologic adjunct therapies
In the last several years, adjunct therapies to exercise
training such as non-invasive ventilatory support and heliox
have been investigated in an attempt to counter the high
respiratory muscle workloads experienced by patients with
COPD during exercise. It is anticipated that by unloading
the inspiratory muscles, such strategies might enable indi-
viduals to exercise at higher intensities, thereby increasing
also the training load to the peripheral muscles and
enhancing the physiologic benefits of exercise training.
Non-invasive ventilatory support
Although non-invasive mechanical ventilation has tradi-
tionally been used with patients who have respiratory
failure or sleep apnea,108,109 it has recently gained more
attention as a potential tool for increasing exercise toler-
ance during pulmonary rehabilitation in patients with
COPD.110 Non-invasive ventilatory support (NIVS) differs
from traditional invasive mechanical ventilation, by the
fact that it does not require the patient to be intubated
(i.e. endotracheal or nasotracheal tube) for delivery of the
positive pressure.111 NIVS can be delivered through
a variety of interfaces such as a mouthpiece, nasal prongs,
or facemask.39,112,113
The modes of mechanical ventilation that have been
used for the delivery of NIVS during exercise include: (1)
continuous positive airway pressure (CPAP), which delivers
a constant positive pressure that elevates the baseline
pressure (airway pressure which is constantly higher than
atmospheric pressure)38,114; (2) bilevel positive airway
pressure (BiPAP) provides continuous positive pressure at
two levels, a higher one for inspiration (IPAP) and a lower
for expiration (EPAP), where both are above atmospheric
Mechanisms of adjunct therapies in COPD 619pressure, and the difference between IPAP and EPAP is
a reflection of the amount of pressure support provided to
the patient115e122; (3) pressure support ventilation
(PSV),123e127 which is a pressure-targeted mode whereby
each breath is patient triggered and cycled; and (4)
proportional assist ventilation (PAV)128e132 which provides
assist in proportion to the patient’s spontaneous effort,
according to the equation of motion (requiring the deter-
mination of elastance and resistance and instantaneous
measures of flow and volume). This requires that the
pressure that is delivered within a breath is continuously
readjusted in proportion to the pressure that is generated
by the inspiratory muscles, determined using instantaneous
measurements of inspiratory airflow and volume.128Effect of NIVS on respiratory and peripheral
muscles and their interaction
There is evidence that NIVS unloads the inspiratory muscles
and reduces the work of breathing both at rest and during
exercise.127,133,134 NIVS has also been shown to decrease
dyspnea, and increase endurance time in individuals with
moderate-to-severe COPD.38,103,127,129,135,136 Previous
studies have demonstrated a relationship between
decreased dyspnea and reduced work of breathing127,135,136
as well as decreased dyspnea and diaphragm deactiva-
tion.137 Unloading the respiratory muscles during high-
intensity exercise (70e80%Wmax) using NIVS has also been
found to improve peripheral muscle oxygenation117,138 and
to reduce blood lactate levels129,139 which in turn not only
reduces the occurrence of leg fatigue, but also further
decreases respiratory drive and dyspnea,129,139 and thereby
has the potential to decrease ventilatory limitation to
exercise.
Several studies have demonstrated that NIVS adminis-
tration during exercise increases VE as a result of both
increased VT and RR
127,129 or only VT,
38 whereas others have
reported no change in VE for a given work load.
103,125,135,140
There is evidence, however, that NIVS promotes a reduction
in inspiratory work load, whether127 or not135 VT and end-
inspiratory lung volume are increased.133,141 Although
NIVS has no direct effect on end-expiratory lung
volume,38,133,141 PSV during exercise has been reported to
promote greater diaphragm muscle deactivation in patients
with COPD compared to healthy individuals,133 supporting
the unloading effect of NIVS.
In patients with more severe COPD, up to 50% of the
whole body VO2 during exercise goes to the respiratory
muscles due to an increased work of breathing,142
enhancing the likelihood of the occurrence of the respira-
tory steal phenomenon.10,103 Several lines of evidence
suggest that reducing the work of breathing via NIVS may
decrease ventilatory muscle blood flow requirements and
allow a fraction of the limited CO to be redirected to the
locomotor muscles, thereby improving peripheral muscle
perfusion, and in turn exercise capacity.103,143 These
responses to NIVS have been found to improve endurance
time in both healthy individuals104,105 and patients with
COPD.117,138
The effects of NIVS on the cardiac performance are
complex, with most resulting from an NIVS associated risein mean intra-thoracic pressure and a fall in transmural
pressure.134,144e146 In a study evaluating the effect of
PSVþPEEP, Oliviera et al.138 showed that NIVS promoted an
increase in stroke volume, HR, CO, and ultimately exercise
endurance in one subgroup of COPD patients; however, in
another subgroup, NIVS resulted in a decreased stroke
volume and HR, thereby reduced CO with no improvement
in exercise endurance. The study found that patients in the
latter subgroup tended to be more hyperinflated, suggest-
ing that NIVS may have a deleterious effect on hemody-
namics and exercise tolerance in COPD patients who exhibit
greater static hyperinflation.
Although there is no evidence to date supporting the use
of one mode of NIVS over another, PAV has been advocated
for exercise training because it is believed to enhance the
synchrony between patient effort and ventilatory
support128,147 thus improving patient comfort, reducing
dyspnea and increasing exercise tolerance.129,130 However,
the need for continuous measurement of the patient’s
respiratory mechanics (i.e., resistance, elastance, and
iPEEP) and adjustment of ventilator settings greatly
increases the complexity of this mode of mechanical
ventilation.
From the accumulated evidence, there is ample empir-
ical data showing that NIVS applied during exercise unloads
the inspiratory muscles, decreases the drive to breathe
thereby reducing dyspnea, delays lactate buildup, and
ultimately improves exercise performance among patients
with COPD. Such improvements, however, vary consider-
ably among individuals. Moreover, there is inconsistent data
corroborating the use of NIVS during routine pulmonary
rehabilitation programs for increasing the overall benefit of
pulmonary rehabilitation compared to training alone.132
Discomfort to ventilator settings and/or the interface
used to deliver the assist120 are factors that may contribute
to lack of tolerance to NIVS, and thus compliance to the
exercise program. NIVS delivery during exercise is labor
intensive and may consequently increase the cost of the
pulmonary rehabilitation program. NIVS should therefore
only be considered in selected patients with COPD who
demonstrate acute benefits from this intervention.Heliox
The complex configuration of the bronchial tree, together
with its branching angles and the internal airway diameter
with its degree of roughness causes airflow to change from
a turbulent to a laminar flow pattern as air moves from the
central to the conductive and peripheral airways.148,149
Turbulent flow is further increased in patients with COPD
consequent to airway inflammation and a loss of alveolar
tethering, which causes narrowing of the airways. The
resultant effect in such patients is an increased airway
resistance and increased work of breathing at rest that
becomes even more prominent during exercise.150
Breathing a low-density gas mixture, such as normoxic
heliox (HeeO2) e a mixture of 79% helium and 21% O2 (79%
Hee21% O2), decreases airway resistance by maintaining or
re-establishing laminar flow within the tracheobronchial
tree at higher flow rates.151e157 Similar to NIVS, heliox can
be delivered non-invasively using different delivery
620 A.M. Moga et al.methods with a variety of patient interfaces such as
a mouthpiece or facemask. The gas mixture is available in
tanks of different sizes, with the 50l tank being the most
frequently used. The tanks are pressurized at approxi-
mately 200 bar for a normoxic HeeO2 mixture, and the air
regulators are connected to the ventilator156 from which
the mixture is delivered to the patient.Effect of heliox on respiratory and peripheral
muscles and their interaction
The administration of heliox, which is approximately three
times less dense than air, during exercise in individuals with
airflow obstruction has been shown to reduce resistive work
of breathing and increase maximum expiratory flow, thus
promoting faster lung emptying.40,158 In addition, evidence
shows that heliox breathing increases VE during exer-
cise40,152,159e162 and also improves exercise toler-
ance,40,152,159,161,162 while reducing dynamic hyperinflation
and dyspnea at isotime.41,152,159,160,162 This indicates that
heliox is able to alleviate dyspnea and the work of breathing
by primarily reducing ventilatory constraints.40,41,152,162
Using esophageal and gastric balloon catheters, Vogiatzis
et al.160 recently demonstrated the positive effect of heliox
on reducing the work of the inspiratory and expiratory
muscles during exercise.160
There is emerging evidence which suggests that heliox-
induced respiratory muscle unloading also improves distri-
bution of the CO to the peripheral muscles during bicycle
exercise in COPD patients.10,103,159,160 Richardson et al.10
showed that heliox administration promoted an increased
VO2peak and peak work load during whole body cycling
exercise, with no change in arterial O2 saturation, sug-
gesting that the VO2 increased secondary to enhanced
peripheral O2 availability and improved perfusion of the
peripheral muscles.
Respiratory muscle unloading via heliox administration
has also been associated with an improved O2 delivery and
extraction in the exercising locomotory muscles in
moderate-to-severe COPD.40 The increase in peripheral
muscle O2 delivery has been assumed to result from
a redistribution of blood flow from the respiratory to the leg
muscles.10,40 Interestingly, a recent study found that heliox
breathing during near-maximum exercise (i.e., 75% peak
work load) improved both quadriceps and intercostal
muscle O2 delivery due to an increase in both arterial O2
content and quadriceps and intercostal muscle blood flow
in patients with moderate-to-severe COPD with static but
not dynamic hyperinflation.160 In contrast to the previous
studies, these findings do not support the “respiratory
steal” phenomenon. Instead, it was concluded that the
increased muscle blood flow and perfusion was due to
a reduction in the work performed by the respiratory
muscles.
In addition to the normoxic heliox, the effects of
different O2 concentrations (hyperoxia) in the heliox gas
mixture have also been investigated. In these studies,
improvement in exercise performance was associated with
increased ventilatory capacity and decreased dynamic
hyperinflation152 and dyspnea.41,152 These studies indicate
that compared to either normoxic heliox or hyperoxiaalone, administration of a combination of helium and
hyperoxia may provide a greater effect in reducing dynamic
hyperinflation and work of breathing (WOB) and improving
exercise performance.
Heliox breathing, similar to NIVS, unloads the respiratory
muscles and relieves both dyspnea and leg discomfort during
exercise. This allows COPD patients to exercise longer prior
to exhaustion and enhances the physiological training
effect,162 which in turn, could ultimately result in an
improved activity of daily life and HRQoL.41,160 Despite the
current findings, the overall cost of the ventilator set-up and
the gas mixture makes the use of this therapy cumbersome/
impractical and/or too expensive to be incorporated into
routine pulmonary rehabilitation programs or training at
home. Notwithstanding the evidence to support the use of
heliox as an adjunct to exercise, further studies are needed
to identify those individuals most likely to benefit from this
intervention. Furthermore, studies are needed to deter-
mine the long-term utility of heliox during rehabilitation
programs in COPD patients and determine how best to
incorporate the latter into routine clinical practice.
Supplemental oxygen
In certain individuals with COPD, ventilation-perfusion
mismatch and hypoventilation,163 can lead to impaired
gas exchange and hypoxemia164 at rest and/or during
exercise.112,165 Studies have shown that in patients with
severe COPD, even routine daily activities such as walking,
stair-climbing, washing, or eating can induce hypox-
emia.166,167 Hypoxemia stimulates ventilatory drive, with
the goal of increasing VE, lowering PaCO2 and in turn
causing vasodilatation of the vascular bed, tachycardia,
and an increased CO.112,168 Chronic hypoxemia can addi-
tionally lead to pulmonary hypertension and cor pulmonale
(i.e. right heart failure), thereby reducing CO and impairing
O2 delivery.
169 With these factors compounding the effects
of hyperinflation, it becomes evident that the hypoxemic
patient with COPD is especially susceptible to lactic
acidosis, muscle fatigue and reduce exercise
capacity.112,169
Effect of supplemental oxygen on the ventilatory
and peripheral muscles and their interaction
Administration of supplemental O2 during exercise to
patients with COPD who are hypoxemic at rest and/or who
desaturate with exercise has been shown to reduce VE
170,
RR and ventilatory drive171e173 for a given exercise work
load. The lower VE which occurs secondary to a lower RR,
has been reported to promote a reduction in dynamic
hyperinflation,172 thus placing the diaphragm on a more
optimal contractile portion of its lengthetension curve. O2
supplementation in hypoxemic patients has been reported
to improve the diaphragm’s ability to sustain dynamic
work,174 to increase exercise endurance and to delay the
onset of respiratory muscle fatigue175 and dyspnea.176
Interestingly, the association between increased endur-
ance time with supplemental O2 and the delayed onset of
diaphragmatic fatigue has also been found in several
studies that examined healthy individuals breathing against
Mechanisms of adjunct therapies in COPD 621an inspiratory resistance.177,178 While some authors have
suggested that the lower VE that occurs with supplemental
O2 is related to slower ventilatory kinetics in such hypox-
emic patients,171 others have attributed the decreased VE
to delayed lactate accumulation, secondary to an increased
peripheral muscle O2 delivery, both in hypoxemic
179and
non-hypoxemic patients.180 Evidence for the latter comes
from a strong correlation between the decrease in VE and
fall in lactate accumulation (rZ 0.88, pZ 0.001).179
Similar to the findings in hypoxemic patients, several
studies have likewise reported reductions in the RR, VE,
42
respiratory drive and dynamic hyperinflation42,43,180 along
with improvements in exercise tolerance180,181 in normoxic
COPD patients receiving supplemental O2 during exercise.
The mechanism linking reduced respiratory drive and
improved exercise tolerance is said to be the prolongation
of expiratory duration which reduces dynamic hyperinfla-
tion and the elastic work of breathing.42,43,180 In addition, it
was shown that the decreased ventilation observed with
supplemental O2 during exercise in normoxemic patients
resulted is an increased mean femoral O2 delivery, sug-
gesting that a part of the blood flow may have been
redistributed from the ventilatory to the peripheral
muscles.182 However, the increased peripheral muscle
blood flow during exercise may not necessarily be the result
of a blood flow redistribution mechanism, since a concomi-
tant increased inspiratory muscle blood flow has also been
found with adjunct therapies that decrease the work of
breathing, suggesting that other factors/mechanisms may
be implicated.160 Interestingly, Siqueira et al.183 recently
showed that despite improved central O2 delivery and blood
oxygenation with supplemental O2 administration, some
normoxemic COPD patients do not benefit from O2 supple-
mentation during exercise due to an impaired intra-
muscular O2 utilization.
Although the current evidence demonstrates that
supplemental O2 can improve O2 saturation and peripheral
tissue oxygenation, reduce dyspnea, and increase exercise
capacity in both hypoxemic and non-hypoxemic COPD
patients, the effects vary considerably among individual
patients. Interestingly, Emtner et al.42 found that non-
hypoxemic patients, who acutely improved exercise toler-
ance with supplemental O2, benefited more from using this
therapy during exercise training in a pulmonary rehabili-
tation program. However, use of supplemental O2 during
exercise training for non-hypoxemic patients is not routine
clinical practice at this point in time.Conclusion
Although considerable research has been devoted to the
effect of adjunct therapies for exercise training that may
be useful in pulmonary rehabilitation programs, less is
known about which patients are most likely to benefit from
them. Reducing the work of breathing, dyspnea and
peripheral muscle fatigue in patients with COPD is a key
mechanism for improving exercise tolerance and activity. In
the current review, three physiologically based interven-
tions able to improve exercise tolerance have been dis-
cussed. It should be noted, however, that none of these
therapies is currently routinely used in the context ofpulmonary rehabilitation, apart from supplemental O2 for
patients who have resting and/or exercise-induced O2
desaturation, given that none has been proven to improve
overall magnitude and/or duration of gains made in the
context of routine clinical pulmonary rehabilitation
programs. Although the administration of non-invasive
ventilatory support, heliox and supplemental O2 during
exercise have been shown to unload the inspiratory
muscles, reduce breathlessness, and enhance exercise
endurance in patients with moderate-to-severe COPD,
current available data demonstrates significant variability
in their effectiveness across patients. Whether or not the
symptoms limiting exercise contribute to such variability is
unknown, raising the question whether patients who are
limited by dyspnea obtain greater benefits from these
adjunct therapies during exercise than those who are
limited by leg fatigue. We propose that these techniques
should be targeted towards individuals who show the most
promising response. Examination of the acute effects of
these adjunct therapies on exercise may provide insight
into why some patients experience a greater benefit in use
of these adjunct therapies during exercise training than
others and may help to identify the most appropriate
candidates for these forms of therapy.Conflict of interest
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